Definitive Healthcare (NASDAQ:DH) Receives “Hold” Rating from Needham & Company LLC

Needham & Company LLC reiterated their hold rating on shares of Definitive Healthcare (NASDAQ:DH) in a report published on Friday morning,Benzinga reports.

Several other research firms also recently commented on DH. Morgan Stanley decreased their price objective on Definitive Healthcare from $9.00 to $5.00 and set an “equal weight” rating for the company in a report on Tuesday, August 6th. BTIG Research started coverage on Definitive Healthcare in a report on Tuesday, September 17th. They set a “buy” rating and a $7.00 price objective for the company. Robert W. Baird decreased their price objective on Definitive Healthcare from $6.00 to $5.00 and set a “neutral” rating for the company in a report on Wednesday, August 7th. Deutsche Bank Aktiengesellschaft decreased their price objective on Definitive Healthcare from $7.00 to $5.00 and set a “hold” rating for the company in a report on Friday, August 9th. Finally, Stifel Nicolaus cut their target price on Definitive Healthcare from $9.50 to $7.50 and set a “buy” rating on the stock in a research report on Wednesday, July 31st. One investment analyst has rated the stock with a sell rating, seven have given a hold rating and three have given a buy rating to the company’s stock. According to MarketBeat.com, the company has a consensus rating of “Hold” and a consensus price target of $5.81.

Definitive Healthcare Stock Down 1.6 %

Shares of DH traded down $0.07 during mid-day trading on Friday, reaching $4.24. 1,200,343 shares of the company were exchanged, compared to its average volume of 326,752. Definitive Healthcare has a 52 week low of $3.19 and a 52 week high of $10.62. The company has a debt-to-equity ratio of 0.27, a current ratio of 2.40 and a quick ratio of 2.40. The business has a 50 day simple moving average of $4.36 and a two-hundred day simple moving average of $5.01.

Institutional Trading of Definitive Healthcare

A number of hedge funds and other institutional investors have recently made changes to their positions in DH. Vanguard Group Inc. increased its stake in Definitive Healthcare by 1.5% in the 1st quarter. Vanguard Group Inc. now owns 4,535,377 shares of the company’s stock worth $36,600,000 after acquiring an additional 67,068 shares during the last quarter. Massachusetts Financial Services Co. MA increased its stake in Definitive Healthcare by 28.3% in the 2nd quarter. Massachusetts Financial Services Co. MA now owns 4,426,420 shares of the company’s stock worth $24,168,000 after acquiring an additional 976,279 shares during the last quarter. Millennium Management LLC bought a new position in Definitive Healthcare in the 2nd quarter worth about $9,283,000. Granite Investment Partners LLC increased its stake in Definitive Healthcare by 22.5% in the 2nd quarter. Granite Investment Partners LLC now owns 884,872 shares of the company’s stock worth $4,831,000 after acquiring an additional 162,432 shares during the last quarter. Finally, 272 Capital LP bought a new position in Definitive Healthcare in the 2nd quarter worth about $3,480,000. 98.67% of the stock is currently owned by institutional investors.

Definitive Healthcare Company Profile

Definitive Healthcare Corp., together with its subsidiaries, provides software as a service (SaaS) healthcare commercial intelligence platform in the United States and internationally. Its SaaS platform provides information on healthcare providers and their activities to help its customers from product development to go-to-market planning, and sales and marketing execution.